Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
Cash Earnings per Share (CEPS)

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   CEPS(Rs) 58.4140.8340.4335.2528.84

What is the latest Cash Earnings per Share (CEPS) ratio of MANKIND PHARMA ?

The latest Cash Earnings per Share (CEPS) ratio of MANKIND PHARMA is 58.41 based on Mar2024 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar202458.41
Mar202340.83
Mar202240.43
Mar202135.25
Mar202028.84

How is Cash Earnings per Share (CEPS) of MANKIND PHARMA Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2024 58.41
43.06
Mar2023 40.83
0.99
Mar2022 40.43
14.70
Mar2021 35.25
22.23
Mar2020 28.84 -

Other Financial Ratios of MANKIND PHARMA


Compare Cash Earnings per Share (CEPS) ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹101,363.4 Cr 2.4% 7.1% 3.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,155.0 Cr -3.9% 3% 7.9% Stock Analytics
DIVIS LABORATORIES ₹147,295.0 Cr -5% -1.1% 71.6% Stock Analytics
CIPLA ₹116,664.0 Cr -4.4% 0.2% -1.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,678.0 Cr -1.6% 6.5% 26.2% Stock Analytics
DR REDDYS LABORATORIES ₹96,162.6 Cr -2.4% 2.4% -5.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

2.4%

7.1%

3.9%

SENSEX

-2.5%

1.9%

4.9%


You may also like the below Video Courses